Oscar Paul Kuipers

This inventor holds 6 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Applied Nanosystems B.v., Lanthiopep B.v., Stichting Katholieke Universiteit. Active years: 2005-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Oscar Paul Kuipers. Retrieved from https://idiyas.com/inventor/oscar-paul-kuipers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 3)

% Patents Active = 33.3

CIPO Patents = 3

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 5.8

ph-index = 4

Forward Citations = 38(Granted Patents)

Company Filing History:

4 out of 16

Applied Nanosystems B.v.

Stichting Katholieke Universiteit

patents

Years Active: 2005-2019

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10485860 - Virulence factors of (2019-11-26),

2. 8835616 - Methods for the production and secretion of modified peptides (2014-09-16),

3. 7858357 - Immunization with bacterial ghost-based vaccines (2010-12-28),

4. 7541039 - Immunization with bacterial ghost-based vaccines (2009-06-02),

5. 7067639 - Method to provide bacterial ghosts provided with antigens (2006-06-27),

6. 6896887 - Bacterial ghosts provided with antigens (2005-05-24),

Title: Oscar Paul Kuipers: Innovator in Vaccine Development and Peptide Production

Introduction

Oscar Paul Kuipers is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the fields of vaccine development and peptide production, holding a total of 6 patents. His work focuses on essential proteins and genes that play a crucial role in virulence, making them ideal candidates for vaccine preparations against pneumococcal infections.

Latest Patents

Among his latest patents, one invention provides proteins and genes essential for survival and virulence in vivo, which are promising candidates for vaccine development against pneumococcal infections. Additionally, he has developed methods for the production and secretion of modified peptides in recombinant host cells. This invention involves a nucleic acid construct that encodes a polypeptide with specific features that facilitate its production and secretion, enhancing the efficiency of biologically active peptide generation.

Career Highlights

Oscar has worked with several prominent organizations, including Applied Nanosystems B.V. and Radboud University Nijmegen Medical Centre. His experience in these institutions has allowed him to collaborate on innovative projects that advance scientific knowledge and practical applications in biotechnology.

Collaborations

Some of his notable coworkers include Cornelis Johannes Leenhouts and Ranjan Ramasamy. Their collaborative efforts have contributed to the success of various research initiatives and patent developments.

Conclusion

Oscar Paul Kuipers is a distinguished inventor whose work in vaccine development and peptide production has made a significant impact in the field of biotechnology. His innovative patents and collaborations continue to pave the way for advancements in medical science.

Profile summary based on public USPTO records.